The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis

Basu S.; Lin P.; Rowntree C.; Saha V.

首页> 外文期刊>Pediatric blood & cancer >The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis

【24h】

The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis

机译：Pegaspargase对急性淋巴细胞白血病第一线治疗的成本效益：一种成本实用性分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2017年第3期|共2页
作者
Basu S.; Lin P.; Rowntree C.; Saha V.;
展开▼
作者单位

Shire Med Affairs Oncol Staines Upon Thames England;

Shire Oncol Cambridge MA USA;

Univ Hosp Wales Cardiff S Glam Wales;

Univ Manchester Paediat Oncol Manchester Lancs England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis [J] . Basu S., Lin P., Rowntree C., Pediatric blood & cancer . 2017,第Suppla3期

机译：Pegaspargase对急性淋巴细胞白血病第一线治疗的成本效益：一种成本实用性分析
2. Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [J] . Maria Mareque, Pau Montesinos, Patricia Font, ClinicoEconomics and Outcomes Research . 2021,第a期

机译：Gemtuzumab ozogamicin在西班牙CD-33阳性急性髓性白血病患者术语中的成本效果分析
3. Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain [J] . Josep Maria Ribera Santasusana, Alejandra de Andrés Salda?a, Nuria García-Mu?oz, ClinicoEconomics and Outcomes Research . 2020,第4期

机译：在西班牙儿童和年轻成人中治疗Tisagenlecleel的成本效果分析在西班牙儿童和年轻成人中的难治
4. Research and Treatment of Childhood Acute Lymphoblastic Leukaemia [C] . . 2006

机译：儿童急性淋巴细胞白血病的研究与治疗
5. Retrospective analysis of survival and treatment related mortality following a myeloablative hematopoietic stem cell transplant in childhood acute lymphoblastic leukemia. [D] . Dasgupta, Sreejeta. 2010

机译：儿童急性淋巴细胞白血病清髓性造血干细胞移植后生存和治疗相关死亡率的回顾性分析。
6. The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis [O] . Xingdi Hu, Kingsley P. Wildman, Subham Basu, 2019

机译：pegaspargase与天然天冬酰胺酶在急性淋巴细胞白血病一线治疗中的成本-效果：基于英国的成本-效用分析
7. Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [O] . Maria Mareque, Pau Montesinos, Patricia Font, 2021

机译：Gemtuzumab ozogamicin在西班牙CD-33阳性急性髓性白血病患者术语中的ozogamicin成本效果分析

The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis

著录项

相似文献

相关主题

期刊订阅